Reported positive update from Phase 2 CRDF-004 trial in first-line RAS-mutated mCRC, with the 30 mg onvansertib + FOLFIRI/bev arm demonstrating: ...
Dow Inc. is downgraded to Hold, as shares approach a fair value of $31–$33 amid a prolonged chemicals sector downturn. Read ...
A new report by ambulance services says "out-of-hospital cardiac arrests" remain a major public health challenge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results